Clarius Group, LLC Novo Nordisk A S Transaction History

Clarius Group, LLC

$1.44 Billion
Q4 2024

A detailed history of Clarius Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Clarius Group, LLC holds 10,930 shares of NVO stock, worth $990,148. This represents 0.07% of its overall portfolio holdings.

Number of Shares

10,930

Previous 13,692 20.17%

Holding current value

$990,148

Previous $1.63 Million 42.33%

% of portfolio

0.07%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	SELL	$85.0 - $120.04 $234,770 - $331,550	-2,762 Reduced 20.17%	10,930 $940,000
Q3 2024 Oct 09, 2024	SELL	$119.07 - $145.42 $141,812 - $173,195	-1,191 Reduced 8.0%	13,692 $1.63 Million
Q2 2024 Jul 11, 2024	SELL	$122.71 - $146.91 $292,540 - $350,233	-2,384 Reduced 13.81%	14,883 $2.12 Million
Q1 2024 Apr 17, 2024	SELL	$102.11 - $135.92 $126,412 - $168,268	-1,238 Reduced 6.69%	17,267 $2.22 Million
Q4 2023 Jan 29, 2024	BUY	$87.78 - $105.45 $8,163 - $9,806	93 Added 0.51%	18,505 $1.91 Million
Q3 2023 Oct 19, 2023	BUY	$90.94 - $199.54 $791,087 - $1.74 Million	8,699 Added 89.56%	18,412 $1.67 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $6,395 - $7,078	41 Added 0.42%	9,713 $1.57 Million
Q1 2023 Apr 17, 2023	BUY	$132.34 - $159.14 $12,307 - $14,800	93 Added 0.97%	9,672 $1.54 Million
Q4 2022 Jan 25, 2023	SELL	$102.55 - $135.33 $7,998 - $10,555	-78 Reduced 0.81%	9,579 $1.3 Million
Q3 2022 Oct 24, 2022	BUY	$95.28 - $116.93 $205,995 - $252,802	2,162 Added 28.85%	9,657 $962,000
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $151,246 - $178,451	1,465 Added 24.3%	7,495 $835,000
Q4 2021 Feb 02, 2022	BUY	$95.88 - $117.08 $70,567 - $86,170	736 Added 13.9%	6,030 $675,000
Q3 2021 Oct 18, 2021	BUY	$84.42 - $106.62 $4,474 - $5,650	53 Added 1.01%	5,294 $508,000
Q2 2021 Aug 06, 2021	BUY	$67.66 - $84.76 $55,345 - $69,333	818 Added 18.49%	5,241 $439,000
Q1 2021 Apr 27, 2021	SELL	$67.06 - $75.82 $23,806 - $26,916	-355 Reduced 7.43%	4,423 $298,000
Q4 2020 Jan 15, 2021	BUY	$63.89 - $73.8 $24,789 - $28,634	388 Added 8.84%	4,778 $334,000
Q2 2020 Jul 08, 2020	BUY	$58.54 - $67.94 $7,727 - $8,968	132 Added 3.1%	4,390 $287,000
Q1 2020 Apr 24, 2020	SELL	$49.46 - $64.78 $98 - $129	-2 Reduced 0.05%	4,258 $256,000
Q4 2019 Jan 22, 2020	BUY	$49.86 - $58.26 $4,238 - $4,952	85 Added 2.04%	4,260 $266,000
Q3 2019 Oct 23, 2019	BUY	$47.54 - $53.43 $198,479 - $223,070	4,175 New	4,175 $216,000

Others Institutions Holding NVO

# of Institutions

1,882

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $204B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Novo Nordisk A S Transaction History